Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India’s Dr. Reddy’s To Reduce Facilities In Foreign Countries

This article was originally published in PharmAsia News

Executive Summary

Except for those in the United States, India's Dr. Reddy's Laboratories plans to close some of its locations around the world, including in China. The decision is the company's response to the global financial crisis. In addition to China, Dr. Reddy's plans to close its operations in Africa, the Middle East and the former countries of the Soviet Union. The Dr. Reddy reductions reflect an overall experience by the Indian pharmaceutical industry, which sees the regions as drains on their resources as their currencies decline in value, according to industry experts. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel